Let’s address the most preventable and reversible component of the huge burden of ageing related musculoskeletal disease that is osteoporosis. We can identify those at risk and have safe, cost-effective treatments. Support and adopt #CaptureTheFracture bit.ly/35iQ0I4

NEW Research: a single-centre, randomised, double-blind, placebo-controlled, proof of concept trial at The University of Sheffield Sheffield Hospitals examined the effect of #denosumab on osteolytic lesion activity after total hip #arthroplasty thelancet.com/journals/lanrh… #LancetRheumatology

More than half of repeat hip replacement operations could be prevented with a drug already successfully used to treat osteoporosis, according to a study from @ShefUni_OncMet. sheffield.ac.uk/news/osteoporo…

Congratulations to Professor Mark Wilkinson from @ShefUni_OncMet on your Fellowship Award in recognition of your pioneering research #Orthopedics #orthopedicsurgeon #Fellowship

In celebration of #IWD2021, we're sharing some of our most inspirational ROS clinical and scientific role models. Dr Nicola Peel chairs our Clinical Committee, is a Trustee and led our COVID19 response supporting healthcare professionals to manage patients through the pandemic 🧡

Important message from Dr Caroline Wilson to ALL women (&men!) about #BreastCancer (2hr13 in) ⁦Weston Park Cancer Centre⁩ ⁦@ShefUni_OncMet⁩ ⁦Sheffield Uni News and Views⁩ Breast Cancer Now⁩ ⁦⁦CoppaFeel!⁩ ⁦⁦Becky Measures⁩ #FeelYourselfFriday ⁦ bbc.co.uk/sounds/play/p0…

Online—Osteoporosis in men thelancet.com/journals/landi… #Osteoporosis #fractures #BMD #Men #MensHealth

Loads of great talks at the Mellany Centre Research Day @ShefUni_OncMet

New in #JBMR: Long-Term Selenium-Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo-Controlled Trial #ASBMR Giorgia Perri Fatma Gossiel Lars Folkestad Richard Eastell ow.ly/VjI750KY5ne

Worldwide, one in three women and one in five men aged 50 years and over will sustain a fragility fracture due to #osteoporosis in their remaining lifetimes #WorldOsteoporosisDay #StepUpForBoneHealth #ASBMR Osteoporosis IOF osteoporosis.foundation

Pleased to know our paper investigating the mechanisms of favourable bone structure in obesity is available online. Many thanks to the team! Richard Eastell Fatma Gossiel doi.org/10.1530/EJE-22…

Bone Turnover Markers: Basic Biology to Clinical Applications. Marian Schini et al. & Richard Eastell. Endocr Rev 2022 Dec 13 bit.ly/3FJTMPT …excellent educational review and reference paper …236 pages, 15 tables, 26 figures and 552 references …an absolute must

Excited to present our results at #ECTS2023 and very grateful for the awards Ankita Duseja #ects @ShefUni_OncMet

Talking about training #VolunteersWeek ! Here’s Marion and Tony on their half day with Dave Jenkyns (Pedal Ready) getting confident cycling Rhubarb. We mentor trainee pilots with practice routes, ride shadowing and an info-full induction session. cwasheffield.com/our-pilots/

Many congratulations Richard Eastell on your ASBMR Esteemed Award 👏 Fantastic news and very well deserved. 🥳

#ASBMRBoneThrone Richard Eastell Marian Schini

Pleased to spread info on abaloparatide, the anabolic drug recently approved by NICE.Richard Eastell Sheffield Uni - Clinical Medicine 🦠 💉 🫀💙🔬🩺 Bone-building drug which prevents fractures in people with osteoporosis approved for use in UK – here’s how it works theconversation.com/bone-building-… via The Conversation

Findings in this #JBMR article indicate an increase in osteoclast precursors in postmenopausal women, which could explain the overshoot phenomenon in bone turnover observed after discontinuing #denosumab Marian Schini Fatma Gossiel Richard Eastell Read more here: ow.ly/R0uG50U4x9U